Skip to main content

Yan Ming's Form 4 filing

Cytek Biosciences, Inc. (CTKB) · filed May 19, 2023

Accession no.
0001209191-23-031276
Filed
May 19, 2023
Trade date
May 18-19, 2023
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $143.8K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Yan MingCIK 0001874041Director, Officer (Chief Technology Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 18, 2023Common StockMOption exerciseAcquired+1,981––7,888,034Direct
May 18, 2023Common StockFTax withholdingDisposed−772$6.69−$5,164.687,887,262Direct
May 18, 2023Common StockMOption exerciseAcquired+4,908––7,892,170Direct
May 18, 2023Common StockFTax withholdingDisposed−1,912$6.69−$12,791.287,890,258Direct
May 19, 2023Common StockSSaleDisposed−20,000$7.19−$143,8007,870,258Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 18, 2023Common StockMOption exerciseDisposed−1,981$0.00$021,142Direct
May 18, 2023Common StockMOption exerciseDisposed−4,908$0.00$0112,905Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)